AVISO IMPORTANTE
Siemens Healthineers informa que los productos de medición de glucosa, comercializados en diversos canales digitales y redes sociales externas a la empresa, están haciendo un uso indebido de la marca e identidad visual de Siemens Healthineers. Estos productos ofrecidos en varios sitios web no forman parte de nuestro portafolio de productos y servicios y no cuentan con los respectivos registros sanitarios. En Latinoamérica, Siemens Healthineers no vende productos y soluciones para personas sin formación técnica. Nuestros destinatarios son profesionales o instituciones sanitarias calificadas. El portafolio de productos y soluciones homologados para la venta en Latinoamérica puede ser consultado en nuestra página web y en nuestros canales oficiales. En caso de duda, consulte a nuestros representantes.
Overview
Diabetes and prediabetes affect approximately 1 in 4 people in North America.1 Although a dynamic experience, 1 in 10 people report that they have experienced some level of homelessness.2 A recent study found diabetes and prediabetes rates among individuals experiencing homelessness within one Alberta metropolitan city to be at least the same if not greater than the general population.3 However, this population has many well described barriers to healthcare.
If left untreated, diabetes can lead to microvascular disease which includes damage to the eyes, nerves, kidneys, and feet. Regular screening is an international standard of care to detect diabetes microvascular complications and allows for proactive referral to specialty care at earlier less costly stages.
This webinar will review an evidence-based and end-user focused strategy created to support early identification and follow up of microvascular disease for patients living with diabetes and experiencing homelessness. Care providers and laboratory professionals will be provided opportunity to learn more about a minimally-disruptive model that leverages point of care tests, and to reflect on how they can pivot to better meet the needs of end-users within their respective practice.
Learning Objectives
- Identify at least four barriers to optimal diabetes care faced by people experiencing homelessness and other social disadvantages
- Examine four critical areas of screening and testing in optimal diabetes management
- Describe the SAFER approach to improve access to quality diabetes care and screening
- Relate why healthcare needs to pivot to better meet the needs of end-users within your own practice
Who Should Attend
Physicians, lab supervisors, lab directors/assistant directors, lab managers (supervisory and/or non-supervisory), point-of-care coordinators, fellows, residents, in-training individuals, other laboratory professionals overseeing/conducting within this topic, emergency shelter and social outreach staff, diabetologists/endocrinologists, diabetes educators, nurses, dietitians, primary care providers, pharmacists, and researchers
Attendees are entitled to ACCENT credits from ADLM.
Speaker Information
David J.T. Campbell, MD, PhD, MSc, FRCPC
University of Calgary, Calgary, Canada
Dr. David Campbell is a medical specialist in Endocrinology & Metabolism and a health services researcher focused on social disparities and their impacts on clinical outcomes of cardiometabolic diseases, like diabetes.
He is the co-director of the Health Policy Trials Unit at the O'Brien Institute for Public Health at the University of Calgary. His research uses mixed methods, interventional approaches, community and stakeholder engagement, and knowledge translation to contribute to reducing the impact of social disadvantage on clinical outcomes by informing health policy and clinical practice.
Speaker Information
Sara Scott, RN, MN, Doctoral Student
University of Calgary, Calgary, Canada
A registered nurse for 20 years, Sara Scott is currently a PhD student in the Department of Community Health Sciences (Health Services Research) at the University of Calgary. Her research interest is on enhancing diabetes wellness and outcomes in equity deserving groups, focused on Indigenous populations.